60 Degrees Pharmaceuticals, Inc.
SXTPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001946563
No open-market purchases or sales by 60 Degrees Pharmaceuticals, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.
Other share classesSXTP
Q1 2025 vs. Q4 2024
How the institutions holding 60 Degrees Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 7 | 6 | −1 |
| Shares | 631.6K | 478.8K | −152.7K (−24.2%) |
| Value | $19.1K | $11.0K | −$8.04K (−42.2%) |
New holders (1)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 15,140 | $348 | 0.00% |
Sold out (2)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Sabby Management, LLC | 161,930 | $4.81K |
| UBS Group AG | 506 | $15 |